Literature DB >> 15082640

Pertussis in Poland.

Anna Gzyl1, Ewa Augustynowicz, Daniel Rabczenko, Grzegorz Gniadek, Janusz Slusarczyk.   

Abstract

BACKGROUND: Since 1997, an unexpected 2-5-fold increase in the incidence of pertussis has been reported in Poland in comparison with the previous 10 years, although the introduction of the diphtheria-tetanus-pertussis (DTP) vaccination in 1960 reduced the incidence of pertussis approximately 100-fold in the 1980s. The aim of the study was to analyse all available data on pertussis in Poland to identify the risks associated with its re-emergence.
METHODS: Available data on notification, incidence, mortality, hospitalization, geographical distribution, incidence according to age, and diagnosis of pertussis were collected from national surveillance monographs and statistically evaluated.
RESULTS: Analyses performed in the study found two periods of rising and falling trends: in the incidence before and after 1989, respectively. Moreover, after 1989, the age-specific incidence among children aged 0-4 years decreased, and among 5-9, 10-14, and 15-19 year olds increased in comparison to the previous decade. The incidence rate of pertussis among infants was similar in both decades analysed. Clustering of pertussis incidence increase in provinces along a line from North East to South West was observed.
CONCLUSIONS: As vaccination coverage did not decrease and diagnostics have not been improved since the 1980s, it is possible that waning immunity and the appearance of Bordetella pertussis vaccine escape mutants are involved in the changing pertussis epidemiological parameters. Further monitoring studies, together with improving diagnostics, might allow more precise epidemiological data to be obtained. An additional booster dose of acellular pertussis vaccine at age 6 years has been included in the current vaccination schedule.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082640     DOI: 10.1093/ije/dyh012

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  17 in total

1.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

2.  Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.

Authors:  Hans O Hallander; Abdolreza Advani; Declan Donnelly; Lennart Gustafsson; Rose-Marie Carlsson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Authors:  Annika Elomaa; Abdolreza Advani; Declan Donnelly; Mia Antila; Jussi Mertsola; Hans Hallander; Qiushui He
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

Authors:  Irja Lutsar; Ioana Anca; Mustafa Bakir; Vytautas Usonis; Roman Prymula; Nuran Salman; Pawel Grezesiowski; Michael Greenberg
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

5.  Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Authors:  Ewa Mosiej; Ewa Augustynowicz; Monika Zawadka; Waldemar Dabrowski; Anna Lutyńska
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

6.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Authors:  Abdolreza Advani; Hans O Hallander; Tine Dalby; Karen Angeliki Krogfelt; Nicole Guiso; Elisabeth Njamkepo; Carl Heinz Wirsing von Könnig; Marion Riffelmann; Frits R Mooi; Per Sandven; Anna Lutynska; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

7.  Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.

Authors:  E Mosiej; M Zawadka; K Krysztopa-Grzybowska; M Polak; E Augustynowicz; K Piekarska; A Lutyńska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-05       Impact factor: 3.267

8.  Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Authors:  Rachel M Stenger; Hugo D Meiring; Betsy Kuipers; Martien Poelen; Jacqueline A M van Gaans-van den Brink; Claire J P Boog; Ad P J M de Jong; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

9.  Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Authors:  Tomasz Niedziela; Iwona Letowska; Jolanta Lukasiewicz; Marta Kaszowska; Anna Czarnecka; Lennart Kenne; Czeslaw Lugowski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

10.  Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Authors:  Rachel M Stenger; Martien C M Poelen; Ed E Moret; Betsy Kuipers; Sven C M Bruijns; Peter Hoogerhout; Marcel Hijnen; Audrey J King; Frits R Mooi; Claire J P Boog; Cécile A C M van Els
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.